Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
The BLA and MAA acceptances represent significant milestones in Polpharma [...]
The BLA and MAA acceptances represent significant milestones in Polpharma [...]
Acceptance reinforces Fresenius Kabi’s strategy to expand its autoimmune biosimilars [...]
First Read is designed to help radiologists meet rising imaging [...]
The clearance marks an important step forward in acute stroke [...]
The FDA determined the SPAXUS Stent to be substantially equivalent [...]
The Procleix Plasmodium Assay aims to improve blood safety by [...]
The Cala kIQ Plus provides new therapy modes and adaptive [...]
SwiftMR®, is an FDA 510(k)-cleared, vendor-neutral MRI image enhancement solution [...]
With these latest clearances, Restore Robotics continues to deliver on [...]
First and only FDA-approved therapy for the treatment of acquired [...]